EXPRESS: Pulmonary vasodilators: beyond the bounds of PAH therapy in COVID-19

2020 
Pulmonary arterial hypertension (PAH) and novel coronavirus (SARS-CoV-2) disease COVID-19 are characterized by extensive endothelial dysfunction and inflammation leading to vascular remodeling and ...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    65
    References
    3
    Citations
    NaN
    KQI
    []